Reinventing
Biopharma

Roivant is focused on rapidly developing innovative medicines through a novel form of industrial organization in R&D.

About Roivant

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.

The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions.

In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.

 

Founder and CEO Vivek Ramaswamy at Roivant Sciences Second Annual Pipeline Day

OUR VANTS

Myovant

Dedicated to women’s health and prostate cancer

OUR VANTS

Enzyvant

Developing transformative therapies for patients with rare diseases

OUR VANTS

Axovant

Finding new solutions in neurology

OUR VANTS

Urovant

Improving quality of life through advancements in urology

OUR VANTS

Altavant

Elevating patient-centric drug development

OUR VANTS

Dermavant

Leading innovation in medical dermatology

OUR VANTS

Aruvant

Developing gene therapies for hematological conditions

OUR VANTS

Respivant

Serving patients suffering from respiratory diseases

OUR VANTS

Metavant

Looking beyond the current options for cardiometabolic disorders

OUR VANTS

Immunovant

Breaking barriers in immunology to restore patient health

OUR VANTS

Genevant

Delivering results through RNA therapeutics

OUR VANTS

Arbutus

Working towards a cure for hepatitis B

OUR VANTS

Sinovant

Bringing medical innovation to China

OUR VANTS

Cytovant

Developing novel and innovative cellular therapeutics in Asia

OUR VANTS

Datavant

Organizing the world's healthcare data

OUR VANTS

Alyvant

Using data to connect patients to therapies

OUR WORK

Pipeline

We have a diverse pipeline of over 45 investigational drugs in 14 therapeutic areas across our family of companies.

COMPANY
COMPOUND
INDICATION
PHASE
Company Compound Indication PRECLIN Phase 1 Phase 2 Phase 3
ENZYVANT RVT-802

Pediatric Congenital Athymia

3

MYOVANT RELUGOLIX

Uterine Fibroids

3

UROVANT VIBEGRON

Overactive Bladder

3

Overactive Bladder in Men with BPH

3

DERMAVANT TAPINAROF

Psoriasis

3

MYOVANT RELUGOLIX

Endometriosis

3

Prostate Cancer

3

SINOVANT LEFAMULIN

Community-Acquired Pneumonia

3

DERAZANTINIB

Intrahepatic Cholangiocarcinoma

3

SNV-003

Delayed Graft Function

3

Acute Kidney Injury

2

LEFAMULIN

ABSSSI

2

NARONAPRIDE

Constipation

2

ALTAVANT RODATRISTAT ETHYL

Pulmonary Arterial Hypertension

2

ARUVANT ARU-1801

Sickle Cell Disease

2

AXOVANT AXO-LENTI-PD

Parkinson's Disease

2

CYTOVANT CVT-DC-01

Acute Myeloid Leukemia

2

DERMAVANT TAPINAROF

Atopic Dermatitis

2

IMMUNOVANT IMVT-1401

Myasthenia Gravis

2

Graves’ Ophthalmopathy

2

METAVANT RVT-1501

Diabetes

2

RVT-1502

Diabetes

2

MYOVANT MVT-602

Female Infertility

2

RESPIVANT RVT-1601

IPF with Chronic Cough

2

UROVANT VIBEGRON

IBS-Associated Pain

2

AXOVANT AXO-AAV-GM1

GM1 Gangliosidosis

2

AXO-AAV-GM2

Tay-Sachs and Sandhoff Diseases

2

Arbutus AB-506

Hepatitis B

1

AB-729

Hepatitis B

1

ALTAVANT RODATRISTAT ETHYL

Idiopathic Pulmonary Fibrosis

1

Sarcoidosis

1

DERMAVANT DMVT-504

Primary Focal Hyperhidrosis

1

CERDULATINIB

Atopic Dermatitis and Vitiligo

1

UROVANT URO-902

Overactive Bladder

1

Arbutus AB-452

Hepatitis B

Preclin

CYTOVANT CVT-TCR-01

Oncologic Malignancies

Preclin

DERMAVANT DMVT-501

Atopic Dermatitis

Preclin

DMVT-503

Acne Vulgaris

Preclin

ENZYVANT RVT-801

Acid Ceramidase Deficiency

Preclin

GENEVANT Additional pan-RNA Programs

Genetic Disorders

Preclin

5 mRNA Programs

Rare Diseases

Preclin

ARUVANT ARU-1801

β-Thalassemia

Preclin

OUR PEOPLE

Leadership

Our leadership team includes industry veterans as well as exceptional leaders from outside of pharma.

The management teams of our subsidiary companies feature some of the most accomplished executives in the biopharmaceutical industry.

Our directors have deep experience in pharmaceutical business development, academic research, public policy, and life sciences investing.

Members of our Public Stakeholder Advisory Group (PSAG) provide ongoing advice on how Roivant can play a role in improving the healthcare system.

WHO WE WORK WITH

Partners

We build our Vants through partnerships with companies and academic institutions that share our commitment to developing new medicines for patients and delivering innovation in healthcare. Select partners are listed below.

STAY INFORMED

News

GET IN TOUCH

Contact Us

Basel, Switzerland
Roivant Sciences GmbH
Viaduktstrasse 8
4051 Basel
Switzerland
New York, NY
Roivant Sciences, Inc.
320 West 37th Street
6th Floor
New York, NY 10018
United States
Durham, NC
Roivant Sciences, Inc.
324 Blackwell Street
Bay 12, Suite 1220
Durham, NC 27701
United States
Brisbane, CA
Myovant Sciences, Inc.
2000 Sierra Point Parkway
9th Floor
Brisbane, CA 94005
United States
Cambridge, MA
Enzyvant
55 Cambridge Parkway
Suite 102W
Cambridge, MA 02142
United States
Irvine, CA
Urovant Sciences, Inc.
5281 California Avenue
Suite 100
Irvine, CA 92617
United States
Long Beach, CA
Dermavant Sciences, Inc.
3780 Kilroy Airport Way
Suite 250
Long Beach, CA 90806
United States
Warminster, PA
Arbutus Biopharma Corporation
701 Veterans Circle
Warminster, PA 18974
United States
San Diego, CA
Respivant Sciences, Inc.
11455 El Camino Real
Suite 460
San Diego, CA 92130
United States
Vancouver, BC
Genevant Sciences Corporation
8900 Glenlyon Parkway
Burnaby, British Columbia V5J 5J8
Canada
Cary, NC
Altavant Sciences, Inc.
6501 Weston Parkway
Suite 330
Cary, NC 27513
United States
San Francisco, CA
Datavant
2 Embarcadero Center
7th Floor
San Francisco, CA 94111
United States
Beijing, China
Sinovant Sciences
77 Jianguo Road
Room 2601-2602A
Chaoyang District
Beijing 100025
China
Shanghai, China
Sinovant Sciences
1717 Nanjing West Road
Room 25, 42nd Floor
Jingan District
Shanhai 200040
China